Multiple Antigen Specific Endogenously Derived T Cells (Technical University of Denmark)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMultiple Antigen Specific Endogenously Derived T Cells (Technical University of Denmark)
Drug Alias NameMASE-T
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocytes stimulantsImmunostimulants
TargetsUpdating
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTechnical University Of Denmark
China Registration ClassN/A

Develop Information

Active CompaniesTechnical University Of Denmark
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A